398.82
0.60%
+2.39
Intuitive Surgical Inc stock is currently priced at $398.82, with a 24-hour trading volume of 698.30K.
It has seen a +0.60% increased in the last 24 hours and a +6.59% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $397.9 pivot point. If it approaches the $399.9 resistance level, significant changes may occur.
Previous Close:
$396.43
Open:
$396.19
24h Volume:
698.30K
Market Cap:
$141.46B
Revenue:
$7.32B
Net Income/Loss:
$1.99B
P/E Ratio:
93.84
EPS:
4.25
Net Cash Flow:
$595.80M
1W Performance:
+3.13%
1M Performance:
+6.59%
6M Performance:
+30.64%
1Y Performance:
+29.39%
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
408-523-2100
Address
1020 Kifer Road, Sunnyvale
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-17-23 | Initiated | HSBC Securities | Buy |
Jul-19-23 | Initiated | Robert W. Baird | Outperform |
Apr-19-23 | Reiterated | BTIG Research | Buy |
Apr-19-23 | Reiterated | BofA Securities | Buy |
Apr-19-23 | Reiterated | Citigroup | Buy |
Apr-19-23 | Reiterated | Evercore ISI | In-line |
Apr-19-23 | Reiterated | JP Morgan | Overweight |
Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
Apr-19-23 | Reiterated | Raymond James | Outperform |
Apr-19-23 | Reiterated | Stifel | Buy |
Apr-19-23 | Reiterated | Truist | Buy |
Apr-19-23 | Reiterated | Wells Fargo | Overweight |
Mar-29-23 | Initiated | UBS | Neutral |
Mar-23-23 | Initiated | William Blair | Outperform |
Oct-18-22 | Initiated | Barclays | Overweight |
Oct-13-22 | Initiated | Mizuho | Neutral |
Oct-12-22 | Initiated | Jefferies | Hold |
Apr-13-22 | Initiated | Truist | Buy |
Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
Mar-02-22 | Resumed | BofA Securities | Buy |
Feb-02-22 | Upgrade | UBS | Neutral → Buy |
Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
Jan-21-22 | Reiterated | BTIG Research | Buy |
Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
Jan-21-22 | Reiterated | Deutsche Bank | Hold |
Jan-21-22 | Reiterated | Evercore ISI | In-line |
Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
Jan-21-22 | Reiterated | Piper Sandler | Neutral |
Jan-21-22 | Reiterated | Raymond James | Outperform |
Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
Jan-21-22 | Reiterated | Stifel | Buy |
Jan-21-22 | Reiterated | UBS | Neutral |
Jan-21-22 | Reiterated | Wells Fargo | Overweight |
Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
Jul-21-21 | Reiterated | BofA Securities | Neutral |
Jul-21-21 | Reiterated | Citigroup | Buy |
Jul-21-21 | Reiterated | JP Morgan | Overweight |
Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
Jul-21-21 | Reiterated | Piper Sandler | Neutral |
Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
Jul-21-21 | Reiterated | Stifel | Buy |
Jul-21-21 | Reiterated | UBS | Neutral |
Jul-21-21 | Reiterated | Wells Fargo | Overweight |
Jul-14-21 | Reiterated | Goldman | Buy |
Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Apr-01-21 | Initiated | Citigroup | Buy |
Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Sep-28-20 | Initiated | Argus | Buy |
Sep-11-20 | Initiated | Wolfe Research | Outperform |
Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
Sep-02-20 | Initiated | Robert W. Baird | Neutral |
Jul-20-20 | Reiterated | Bernstein | Outperform |
Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-17-20 | Downgrade | CFRA | Hold → Sell |
Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
Dec-12-19 | Reiterated | Wells Fargo | Outperform |
Nov-21-19 | Initiated | Oppenheimer | Perform |
Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
Apr-02-19 | Initiated | Deutsche Bank | Buy |
Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
Intuitive Surgical Stock Can Trend Much Higher This Year - MSN
MSN
Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Great Lakes Advisors LLC - MarketBeat
MarketBeat
Intuitive surgical executive sells shares worth over $94k - Investing.com South Africa
Investing.com South Africa
Intuitive Surgical posts fourth-quarter loss on tax expense - Reuters
Reuters
Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells $24,959.97 in Stock - MarketBeat
MarketBeat
Intuitive surgical executive sells shares worth over $94k - Investing.com
Investing.com
Intuitive Surgical Inc Stock (ISRG) Financials Data
Intuitive Surgical Inc (ISRG) Revenue 2024
ISRG reported a revenue (TTM) of $7.32 billion for the quarter ending March 31, 2024, a +13.81% rise year-over-year.
Intuitive Surgical Inc (ISRG) Net Income 2024
ISRG net income (TTM) was $1.99 billion for the quarter ending March 31, 2024, a +51.49% increase year-over-year.
Intuitive Surgical Inc (ISRG) Cash Flow 2024
ISRG recorded a free cash flow (TTM) of $595.80 million for the quarter ending March 31, 2024, a -40.79% decrease year-over-year.
Intuitive Surgical Inc (ISRG) Earnings per Share 2024
ISRG earnings per share (TTM) was $5.54 for the quarter ending March 31, 2024, a +51.37% growth year-over-year.
Intuitive Surgical Inc Stock (ISRG) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Brosius Mark | SVP & Chief Mfg and Supply Cha |
May 17 '24 |
Sale |
396.19 |
63 |
24,960 |
295 |
Miller Brian Edward | EVP & Chief Digital Officer |
May 16 '24 |
Sale |
400.00 |
2,553 |
1,021,200 |
9,619 |
Brosius Mark | SVP & Chief Mfg and Supply Cha |
May 16 '24 |
Sale |
398.28 |
175 |
69,699 |
358 |
Brosius Mark | SVP & Chief Mfg and Supply Cha |
May 15 '24 |
Sale |
387.22 |
175 |
67,764 |
533 |
Brosius Mark | SVP & Chief Mfg and Supply Cha |
May 14 '24 |
Sale |
380.85 |
175 |
66,649 |
708 |
DeSantis Robert | EVP & Chief Strategy & Corp Op |
May 13 '24 |
Option Exercise |
179.70 |
90 |
16,173 |
5,790 |
DeSantis Robert | EVP & Chief Strategy & Corp Op |
May 13 '24 |
Sale |
389.16 |
284 |
110,521 |
5,506 |
Brosius Mark | SVP & Chief Mfg and Supply Cha |
May 13 '24 |
Sale |
389.16 |
175 |
68,103 |
883 |
DeSantis Robert | EVP & Chief Strategy & Corp Op |
May 11 '24 |
Option Exercise |
0.00 |
360 |
0 |
5,867 |
DeSantis Robert | EVP & Chief Strategy & Corp Op |
May 10 '24 |
Option Exercise |
267.19 |
239 |
63,858 |
5,627 |
About Intuitive Surgical Inc
Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. Its da Vinci surgical system include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. The company also manufactures EndoWrist instruments that include forceps, scissors, electrocautery, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, it offers da Vinci Single-Site instruments and accessories that allow surgical systems to work through a single incision; and EndoWrist One vessel sealers that are wristed single-use instruments intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in diameter and tissue bundles that fit in the jaws of the instrument. Further, the company provides EndoWrist stapler, a wristed stapling instrument intended for resection, transection, and/or creation of anastomoses, as well as sells various accessories, including replacement 3-D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci system, as well as sterile drapes for ensuring a sterile field during surgery. Intuitive Surgical, Inc. markets its products directly and through distributors in the United States, Europe, Asia, and internationally. The company was founded in 1995 and is headquartered in Sunnyvale, California.
Cap:
|
Volume (24h):